Pharma and Biotech
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-21 | 133.66 | (166.00) | 23.00p | 30.3 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 198.60 | (83.41) | (11.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 169.67 | (149.77) | (19.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 30.35 | 30.35 | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 97.90p |
Change Today | -0.55p |
% Change | -0.56 % |
52 Week High | 275.00 |
52 Week Low | 92.75 |
Volume | 1,033,836 |
Shares Issued | 862.82m |
Market Cap | £844.70m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:35 | 344,914 @ 97.90p |
16:35 | 576 @ 97.90p |
16:35 | 3,042 @ 97.90p |
16:35 | 1,785 @ 97.90p |
16:35 | 1,140 @ 97.90p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research